Probiotics vs Rapamycin (Sirolimus)
Both are used for immunity. Here's how they compare on human evidence, mechanism, safety and availability — in plain English.
| Probiotics | Rapamycin (Sirolimus) | |
|---|---|---|
| Human evidence | ★★★☆☆ | ★★★★★ |
| Legal status | OTC Supplement | Off-Label, FDA Approved |
| How it works | Live strains that competitively exclude pathogens, produce short-chain fatty acids (butyrate → colonocyte fuel, FFAR signalling), and modulate gut immunity. Effects are strain-specific, not generic. | Binds FKBP12 to inhibit mTOR complex 1 — flipping cells from growth to maintenance (autophagy, stress resistance, less senescence). What mTOR is and why dialling it down matters → the mTOR pathway. The compound-specific nuance is… |
| In plain English | Helpful bacteria that crowd out bad ones and feed your gut lining. The catch: benefits depend on the specific strain, so match strain to goal. | Rapamycin dials the "grow" switch (mTOR) down periodically, flipping cells into "clean and repair." It extends lifespan in every animal tested — the single most reliable longevity drug — but human data is still coming in. Taken weekly, not… |
| Bottom line | Match strain to condition; not interchangeable. | The most compelling longevity drug we have; still needs human RCTs (PEARL, others ongoing). |
| Availability | Available over the counter | Prescription only |
Which is better for immunity?
Rapamycin (Sirolimus) has the stronger human-evidence rating (★★★★★ vs ★★★☆☆), but the right choice still depends on your goal, tolerance and budget.
Full breakdowns: Probiotics · Rapamycin (Sirolimus).
Common questions
Is Probiotics or Rapamycin (Sirolimus) better for immunity?
Rapamycin (Sirolimus) has the stronger human-evidence rating (★★★★★ vs ★★★☆☆), but the right choice still depends on your goal, tolerance and budget.
What's the difference between Probiotics and Rapamycin (Sirolimus)?
Probiotics: Match strain to condition; not interchangeable. — Rapamycin (Sirolimus): The most compelling longevity drug we have; still needs human RCTs (PEARL, others ongoing).